| Product Code: ETC8122034 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malaysia Bacteriophages Therapy Market Overview |
3.1 Malaysia Country Macro Economic Indicators |
3.2 Malaysia Bacteriophages Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 Malaysia Bacteriophages Therapy Market - Industry Life Cycle |
3.4 Malaysia Bacteriophages Therapy Market - Porter's Five Forces |
3.5 Malaysia Bacteriophages Therapy Market Revenues & Volume Share, By Targeted Bacteria, 2021 & 2031F |
3.6 Malaysia Bacteriophages Therapy Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 Malaysia Bacteriophages Therapy Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Malaysia Bacteriophages Therapy Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Malaysia Bacteriophages Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of antibiotic-resistant infections in Malaysia |
4.2.2 Growing awareness about the benefits of bacteriophage therapy among healthcare professionals and patients |
4.2.3 Government initiatives to promote research and development in the field of bacteriophages therapy |
4.3 Market Restraints |
4.3.1 Limited availability of approved bacteriophage therapy products in Malaysia |
4.3.2 Lack of standardization and regulatory framework for bacteriophage therapy |
4.3.3 High cost associated with the development and production of bacteriophage therapies |
5 Malaysia Bacteriophages Therapy Market Trends |
6 Malaysia Bacteriophages Therapy Market, By Types |
6.1 Malaysia Bacteriophages Therapy Market, By Targeted Bacteria |
6.1.1 Overview and Analysis |
6.1.2 Malaysia Bacteriophages Therapy Market Revenues & Volume, By Targeted Bacteria, 2021- 2031F |
6.1.3 Malaysia Bacteriophages Therapy Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.1.4 Malaysia Bacteriophages Therapy Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.1.5 Malaysia Bacteriophages Therapy Market Revenues & Volume, By Streptococcus, 2021- 2031F |
6.1.6 Malaysia Bacteriophages Therapy Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.1.7 Malaysia Bacteriophages Therapy Market Revenues & Volume, By Salmonella, 2021- 2031F |
6.1.8 Malaysia Bacteriophages Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Malaysia Bacteriophages Therapy Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 Malaysia Bacteriophages Therapy Market Revenues & Volume, By Urinary Tract Infections, 2021- 2031F |
6.2.3 Malaysia Bacteriophages Therapy Market Revenues & Volume, By Chronic Otitis, 2021- 2031F |
6.2.4 Malaysia Bacteriophages Therapy Market Revenues & Volume, By Chronic Ulcerative Colitis, 2021- 2031F |
6.2.5 Malaysia Bacteriophages Therapy Market Revenues & Volume, By Bone Infection, 2021- 2031F |
6.2.6 Malaysia Bacteriophages Therapy Market Revenues & Volume, By Wound and Skin Infections, 2021- 2031F |
6.2.7 Malaysia Bacteriophages Therapy Market Revenues & Volume, By Cystic Fibrosis, 2021- 2031F |
6.3 Malaysia Bacteriophages Therapy Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Malaysia Bacteriophages Therapy Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Malaysia Bacteriophages Therapy Market Revenues & Volume, By Topical, 2021- 2031F |
6.3.4 Malaysia Bacteriophages Therapy Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4 Malaysia Bacteriophages Therapy Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Malaysia Bacteriophages Therapy Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Malaysia Bacteriophages Therapy Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.4 Malaysia Bacteriophages Therapy Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 Malaysia Bacteriophages Therapy Market Import-Export Trade Statistics |
7.1 Malaysia Bacteriophages Therapy Market Export to Major Countries |
7.2 Malaysia Bacteriophages Therapy Market Imports from Major Countries |
8 Malaysia Bacteriophages Therapy Market Key Performance Indicators |
8.1 Number of clinical trials conducted for bacteriophage therapy in Malaysia |
8.2 Percentage increase in healthcare professionals trained in bacteriophage therapy |
8.3 Number of research grants awarded for bacteriophage therapy research in Malaysia |
9 Malaysia Bacteriophages Therapy Market - Opportunity Assessment |
9.1 Malaysia Bacteriophages Therapy Market Opportunity Assessment, By Targeted Bacteria, 2021 & 2031F |
9.2 Malaysia Bacteriophages Therapy Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 Malaysia Bacteriophages Therapy Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Malaysia Bacteriophages Therapy Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Malaysia Bacteriophages Therapy Market - Competitive Landscape |
10.1 Malaysia Bacteriophages Therapy Market Revenue Share, By Companies, 2024 |
10.2 Malaysia Bacteriophages Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here